National Athletic Trainers’ Association MRSA Guidelines

Posted in These Categories: News of Hospital Acquired Infections

In June 2010 the National Athletic Trainers’ Association unveiled guidelines to prevent MRSA skin infections at its annual conference.

A study of high school athletes in Nebraska found that the incidence of MRSA infections rose markedly between the 2006-07 and 2007-08 school years, according to the federal Centers for Disease Control and Prevention and the Nebraska Department of Health Community Services.

Among wrestlers, the incidence tripled, going from 19.6 per 10,000 students to 60.1. Among football players in the Nebraska study, published last year in the Journal of School Nursing, the incidence rose five times, from 5 per 10,000 players to 25 in 10,000.

Guidelines:

• Discouraging the sharing of towels, gear, water bottles, hair clippers, and razors.
• Daily disinfection or laundering of sports equipment and clothing.
• Frequent hand-washing and showering.
• Encouraging athletes to check skin daily and report suspicious sores.

Skin infections account for 56 percent of infectious diseases incurred in competitive athletics, according to a study to appear in July in the Journal of Athletic Training.

Medizone International, Inc. (Dually Traded: OTCBB/OTCQB: MZEI)

(http://medizoneint.com)

Medizone International, Inc. is a research and development company engaged in developing its AsepticSure™ System to decontaminate and sterilize hospitals, sports training facilities, schools and other critical infrastructure. A government variant is being developed for bio-terrorism counter measures. Successful decontamination by AsepticSure™ to the 6 log standard or greater has been demonstrated with C.difficile, E coli, Pseudomonas aeruginous, MRSA, VRE and Bacillius subtilis.

Medizone International, Inc.
Post Office Box 742
Stinson Beach, CA 94970
Telephone: 415-868-0300
Fax: 415-868-2344

This release contains certain forward looking statements that involve substantial risks and uncertainties, including, but not limited to, the results of ongoing clinical studies, economic conditions, product and technology development, production efficiencies, product demand, competitive products, competitive environment, successful testing and government regulatory issues. Additional risks are identified in the company’s filings made with the Securities and Exchange Commission.

Tweet This Post